Photocure: Trials in Progress presented at the European Association of Urology 2026 congress aim to enable a more personalized bladder cancer care pathway

Photocure Norway

for further information on our commercial partners.

About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com/news

CONTACT:

For more information, please contact:

Dan Schneider
President and CEO
Photocure ASA
Email: [e-mail]

Erik Dahl
CFO
Photocure ASA
Tel: [phone]
Email: [e-mail]

Priyam Shah
Vice President Investor Relations
Tel : [phone]
Email: [e-mail]

Media enquiries:

Geir Bjørlo
Corporate Communications (Norway)
Tel: [phone]
Email: [e-mail]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/photocure/r/photocure--trials-in-progress-presented-at-the-european-association-of-urology--eau--2026-congress-a,c4321994

The following files are available for download:

https://mb.cision.com/Main/17498/4321994/3985198.pdf 

Release

View original content:https://www.prnewswire.co.uk/news-releases/photocure-trials-in-progress-presented-at-the-european-association-of-urology-eau-2026-congress-aim-to-enable-a-more-personalized-bladder-cancer-care-pathway-302714884.html